BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33392203)

  • 1. Identification of lncRNA-mRNA Regulatory Module to Explore the Pathogenesis and Prognosis of Melanoma.
    Zhang J; Liu H; Zhang W; Li Y; Fan Z; Jiang H; Luo J
    Front Cell Dev Biol; 2020; 8():615671. PubMed ID: 33392203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Long Non-coding and Messenger RNAs Differentially Expressed Between Primary and Metastatic Melanoma.
    Sun L; Guan Z; Wei S; Tan R; Li P; Yan L
    Front Genet; 2019; 10():292. PubMed ID: 31024618
    [No Abstract]   [Full Text] [Related]  

  • 3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.
    Chen G; Yan J
    Curr Protein Pept Sci; 2022; 23(11):791-809. PubMed ID: 36173063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of DGUOK-AS1 as a Prognostic Factor in Breast Cancer by Bioinformatics Analysis.
    Li Y; Liang Y; Ma T; Yang Q
    Front Oncol; 2020; 10():1092. PubMed ID: 32766141
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of MFI2-AS1, a Novel Pivotal lncRNA for Prognosis of Stage III/IV Colorectal Cancer.
    Luo R; Song J; Zhang W; Ran L
    Dig Dis Sci; 2020 Dec; 65(12):3538-3550. PubMed ID: 31960204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Analysis of a Competing Endogenous RNA Network Identifies Seven-lncRNA Signature as a Prognostic Biomarker for Melanoma.
    Liu N; Liu Z; Liu X; Chen H
    Front Oncol; 2019; 9():935. PubMed ID: 31649871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing.
    Yuan CL; Jiang XM; Yi Y; E JF; Zhang ND; Luo X; Zou N; Wei W; Liu YY
    BMC Cancer; 2019 Dec; 19(1):1171. PubMed ID: 31795964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma
    Zhou S; Han Y; Li J; Pi X; Lyu J; Xiang S; Zhou X; Chen X; Wang Z; Yang R
    Front Oncol; 2021; 11():745384. PubMed ID: 34722301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Potential Biomarkers of Prognosis-Related Long Non-Coding RNA (lncRNA) in Pediatric Rhabdoid Tumor of the Kidney Based on ceRNA Networks.
    Wu X; Liu J; Zhu C; Ma M; Chen X; Liu Y; Xia N; Dong Q
    Med Sci Monit; 2020 Dec; 26():e927725. PubMed ID: 33328429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel lncRNA-miRNA-mRNA competitive endogenous RNA network for uveal melanoma prognosis constructed by weighted gene co-expression network analysis.
    Yu H; Cheng Y; Li W; Li Z; Wu P; Qiu S; Zeng B; Huang B
    Life Sci; 2020 Nov; 260():118409. PubMed ID: 32926921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening key lncRNAs for human rectal adenocarcinoma based on lncRNA-mRNA functional synergistic network.
    Zhu X; Wang D; Lin Q; Wu G; Yuan S; Ye F; Fan Q
    Cancer Med; 2019 Jul; 8(8):3875-3891. PubMed ID: 31116002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstruction and Analysis of the Differentially Expressed IncRNA-miRNA-mRNA Network Based on Competitive Endogenous RNA in Hepatocellular Carcinoma.
    Cao D; Wang Y; Li D; Wang L
    Crit Rev Eukaryot Gene Expr; 2019; 29(6):539-549. PubMed ID: 32422009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA-miRNA-mRNA networks and Cox regression models.
    Yao Y; Zhang T; Qi L; Liu R; Liu G; Wang J; Song Q; Sun C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31950990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
    Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
    Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Long Non-Coding RNA Transcriptomic Profiles in Ischemic Stroke.
    He W; Wei D; Cai D; Chen S; Li S; Chen W
    Hum Gene Ther; 2018 Jun; 29(6):719-732. PubMed ID: 29284304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
    Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
    BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.